Top 50 Players in the Gene Therapy Industry: Market Size, Company Profiles and Forecast To 2035
RELEASE DATE: Aug 2025 Author: Spherical InsightsRequest Free Sample Speak to Analyst
Description
According to a research report published by Spherical Insights & Consulting, The Global Gene Therapy Market Size is projected to grow from USD 9.21 Billion in 2024 to USD 69.48 Billion by 2035, at a CAGR of 20.17% during the forecast period 2025–2035. The rising prevalence of genetic and chronic diseases, such as cancer and rare inherited disorders, is driving demand for advanced treatments. Gene therapy offers targeted, potentially curative solutions, fueling investment, research, and market growth.
Introduction
The global gene therapy market is witnessing significant growth, driven by advancements in molecular biology, increased prevalence of genetic and chronic diseases, and growing investment in biotechnology research. Gene therapy aims to treat or prevent diseases by modifying a person's genetic material, offering long-term or potentially curative solutions for conditions such as cancer, genetic disorders, and viral infections. Governments across the globe are actively supporting gene therapy development through regulatory reforms, research funding, and expedited approval pathways. Initiatives such as orphan drug designations, fast-track approvals, and public-private partnerships have accelerated clinical trials and innovation in this field. The market is further supported by rising awareness, improved diagnostics, and technological progress in vector development and gene editing tools like CRISPR. As ethical, safety, and manufacturing challenges are progressively addressed, the gene therapy market is poised for substantial expansion, revolutionizing modern medicine and creating new opportunities for personalized and precision-based therapeutic approaches.
Navigate Future Markets with Confidence: Insights from Spherical Insights LLP
The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.
Unlock exclusive market insights - Download The Brochure now and dive deeper into the future of The Gene Therapy Market
Warehouse Management System Market Size & Statistics
- The Market Size for Gene Therapy Market Was Estimated to be worth USD 9.21 Billion in 2024.
- The Market Size is Going To Expand at a CAGR of 20.17% between 2025 and 2035.
- The Global Gene Therapy Market Size is anticipated to reach USD 69.48 Billion by 2035.
- North America is expected to generate the highest demand during the forecast period in the Gene Therapy Market
- Asia Pacific is expected To Grow the fastest during the forecast period in the Gene Therapy Market.
Regional growth and demand
North America is expected to generate the highest demand during the forecast period in the Gene Therapy Market. This dominance is attributed to its advanced healthcare infrastructure, strong presence of leading biotechnology and pharmaceutical companies, and high investment in R&D. Regulatory bodies like the U.S. Food and Drug Administration (FDA) have established supportive frameworks, including fast-track designations and orphan drug statuses, which accelerate the development and approval of gene therapies. Additionally, increasing awareness of personalized medicine, a rising burden of genetic and chronic diseases, and access to cutting-edge technologies contribute to the region’s market leadership. The presence of numerous ongoing clinical trials and collaborations between academic institutions and industry players further fuel market growth.
Asia Pacific is expected to grow the fastest during the forecast period in the Gene Therapy Market. This growth is driven by rising healthcare investments, increasing prevalence of genetic disorders, and expanding clinical research. Governments in countries like China, Japan, and India are supporting the sector through funding and regulatory reforms. Improved healthcare infrastructure and growing awareness of advanced therapies are boosting demand. Strategic partnerships between local and global biotech firms are further accelerating development.
Top 10 trends in the Gene Therapy Market
- Advancements in Gene Editing Technologies
- Growing Number of Approved Gene Therapies
- Expansion into Rare and Genetic Disorders
- Personalized and Precision Medicine
- Increased Public-Private Collaborations
- Improved Viral and Non-Viral Vectors
- Rising Government Support and Funding
- Focus on Manufacturing and Scalability
- Emergence of In Vivo and Ex Vivo Therapies
- Increasing Clinical Trials and Pipeline Expansion
1. Advancements in Gene Editing Technologies
Cutting-edge tools like CRISPR and TALENs have dramatically improved the precision and efficiency of gene editing. These technologies reduce off-target effects and enhance safety, allowing researchers to develop treatments for a wider range of genetic diseases. Continuous improvements in gene editing methods are accelerating therapy development and broadening clinical applications.
2. Growing Number of Approved Gene Therapies
The gene therapy market is benefiting from an increasing number of regulatory approvals worldwide. Faster approval pathways, such as orphan drug designation and accelerated review, are helping bring therapies to patients more quickly. This growth reflects improved clinical trial outcomes and greater confidence in gene therapy safety and effectiveness.
3. Expansion into Rare and Genetic Disorders
While cancer therapies remain a focus, gene therapy is expanding rapidly into rare and inherited genetic disorders like hemophilia and spinal muscular atrophy. These therapies provide hope for diseases that previously had limited or no treatment options. Advances in genetic diagnostics help identify patients who can benefit from these innovative treatments.
4. Personalized and Precision Medicine
Gene therapies are increasingly being designed to match a patient’s unique genetic profile. This personalized approach improves treatment effectiveness and reduces side effects by targeting specific mutations. Precision medicine is revolutionizing care by moving away from one-size-fits-all treatments toward individualized therapy plans.
5. Increased Public-Private Collaborations
Collaborations between biotech firms, academic institutions, and government agencies are driving innovation in gene therapy. These partnerships pool expertise, resources, and funding to accelerate research and development. Public-private alliances help overcome scientific and regulatory challenges, boosting commercialization efforts.
Empower your strategic planning:
Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the warehouse management system market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.
Top 25 Companies Leading the Gene Therapy Market
- Novartis
- Spark Therapeutics
- Bluebird Bio
- Sangamo Therapeutics
- UniQure
- Audentes Therapeutics
- Pfizer
- Gilead Sciences
- Biogen
- Regeneron Pharmaceuticals
- REGENXBIO
- Avexis
- Sarepta Therapeutics
- Editas Medicine
- CRISPR Therapeutics
- Intellia Therapeutics
- MediGene AG
- Orchard Therapeutics
- MeiraGTx
- Viralgen
- Homology Medicines
- Freeline Therapeutics
- Poseida Therapeutics
- 4D Molecular Therapeutics
- Generation Bio
1. Novartis
Headquarters: Basel, Switzerland
Novartis is a global pharmaceutical leader driving innovation in gene therapy through its groundbreaking work in cell and gene-based treatments. The company’s focus includes CAR-T therapies and innovative gene-editing platforms aimed at curing genetic diseases and cancers. Novartis combines cutting-edge research with strong manufacturing capabilities to deliver transformative therapies that improve patient outcomes worldwide. Their commitment to personalized medicine and regulatory collaboration positions them at the forefront of the gene therapy market.
2. Spark Therapeutics
Headquarters: Philadelphia, Pennsylvania, USA
Spark Therapeutics is a pioneer in gene therapy, renowned for developing Luxturna, the first FDA-approved gene therapy for an inherited retinal disease. The company specializes in adeno-associated virus (AAV)-based therapies targeting genetic disorders. Spark’s innovative pipeline includes treatments for hemophilia and other rare diseases, supported by robust clinical development and manufacturing infrastructure. Its focus on safe, effective, and durable therapies has established Spark as a leader in the gene therapy space.
3. Bluebird Bio
Headquarters: Cambridge, Massachusetts, USA
Bluebird Bio is a biotechnology company dedicated to developing gene therapies for severe genetic diseases and cancer. Known for its lentiviral vector technology, Bluebird has made significant strides with treatments for beta-thalassemia, sickle cell disease, and multiple myeloma. The company emphasizes long-term safety and efficacy, partnering with healthcare providers and regulators to bring personalized therapies to patients with unmet medical needs.
4. Sangamo Therapeutics
Headquarters: Brisbane, California, USA
Sangamo Therapeutics specializes in gene editing and gene therapy using zinc finger nuclease technology. Their platform targets genetic diseases by precisely modifying DNA to correct mutations at the source. Sangamo’s pipeline includes therapies for hemophilia, lysosomal storage disorders, and CNS diseases. The company combines scientific innovation with strategic partnerships to advance clinical programs and scale manufacturing capabilities.
5. UniQure
Headquarters: Lexington, Massachusetts, USA
UniQure is a leader in developing gene therapies for rare diseases, focusing on liver-directed AAV-based treatments. Its flagship product, Glybera, was the first gene therapy approved in Europe, targeting lipoprotein lipase deficiency. UniQure continues to innovate with therapies for hemophilia and Huntington’s disease. The company prioritizes safety, manufacturing excellence, and collaborations to expand the reach of gene therapy worldwide.
Are you ready to discover more about the gene therapy market?
The report provides an in-depth analysis of the leading companies operating in the global gene therapy market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:
Company Profiles
- Novartis
- Business Overview
- Company Snapshot
- Products Overview
- Company Market Share Analysis
- Company Coverage Portfolio
- Financial Analysis
- Recent Developments
- Merger and Acquisitions
- SWOT Analysis
- Spark Therapeutics
- Bluebird Bio
- Sangamo Therapeutics
- UniQure
- Audentes Therapeutics
- Pfizer
- Gilead Sciences
- Biogen
- Regeneron Pharmaceuticals
- Others
Conclusion
The gene therapy market is advancing rapidly through the adoption of cutting-edge gene editing technologies, personalized medicine, and innovative delivery systems. Companies are focusing on precision treatments, improved vector designs, and scalable manufacturing to enhance safety, efficacy, and patient access. Collaborations and increased government support are accelerating clinical development and regulatory approvals. As gene therapies expand beyond rare diseases into broader applications, the industry is moving toward more accessible, targeted, and durable solutions, ushering in a new era of transformative, patient-centric healthcare.
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?